Biochemistry, Genetics and Molecular Biology » "Genetic Transformation", book edited by María Alvarez, ISBN 978-953-307-364-4, Published: September 6, 2011 under CC BY-NC-SA 3.0 license. © The Author(s).

Chapter 3

Genetic Transformation in Tomato: Novel Tools to Improve Fruit Quality and Pharmaceutical Production

By Antonio Di Matteo, Maria Manuela Rigano, Adriana Sacco, Luigi Frusciante and Amalia Barone
DOI: 10.5772/24521

Article top

Genetic Transformation in Tomato: Novel Tools to Improve Fruit Quality and Pharmaceutical Production

Antonio Di Matteo, Maria Manuela Rigano, Adriana Sacco, Luigi Frusciante and Amalia Barone

1. Introduction

Tomato is one of the most important vegetable crop worldwide with a total production of around 141 million tons on a cultivated area of around 5 million hectares (FAOSTAT, 2009, http://faostat.fao.org). Among the most representative countries, Italy contributes with more than 6 million tons to the world production, on a cultivated area of around 117.000 hectares, both in open fields and greenhouses (FAOSTAT, 2009). This crop represents also one of the major products of the food industry worldwide and Italy ranks first for processing tomato production among Countries of the Mediterranean Region (World Processing Tomato Council, 2009, http://www.wptc.to). Indeed, the high variability of tomato fruits, ranging from the cherry type to the big round or elongated berry, supplies both fresh market and processing products, such as paste, juice, sauce, powder or whole. In the last years, tomato consumption has further increased since it was demonstrated that tomato fruit could protect against diseases, such as cancer and cardiovascular disorders, due to its antioxidant properties (Rein et al., 2006). Tomato fruits are particularly rich of nutritional compounds such as lycopene and alfa-carotene, vitamin C, flavonoids and hydroxycinnamic acid derivatives whose intake would account for health benefits.

The cultivated tomato (Solanum lycopersicum) belongs to the Solanaceae family that includes more than 3.000 species, among which 12 represent tomato wild relatives. These species exhibit a wide variety of adaptation to diverse habitats, plant morphology, fruit size and colour, the latter varying from green to white, yellow, pink, red, brown, depending mainly on the metabolites fruit content. The wild related tomato species represent a potential reservoir of useful genes that have been greatly used in breeding programs (Bai & Lindhout, 2007; Gur & Zamir, 2004). Indeed, this vegetable is one of the most investigated crop both at genetic and genomic level not only because of its economic importance but also because it is one of the best characterized plant systems. It has diploid genetics (24 somatic chromosomes), a small genome size (950 Mb per haploid nucleus), is self-pollinated, has a short generation time, is easily reproduced by seed and vegetative propagation and is cross-compatible with many wild species. All these characteristics make it amenable to genetic analysis.

The huge amount of researches focused on tomato allowed the development of new tools and platforms for genetics and genomics analyses (Barone et al., 2008). Since tomato is considered the model species among the Solanaceae, these novel techniques have been also exploited for other economically important crops, such as potato, pepper, and eggplant. Moreover, due to the high sinteny existing among Solanaceae species, tomato was chosen as reference genome to be completely sequenced by the International Tomato Genome Sequencing Consortium at the end of the year 2003 (Mueller et al., 2005). Molecular comparative mapping studies revealed a high level of conserved gene content and order within this family (Wu & Tanksley, 2010), as well as within other families (i.e grasses, crucifers, legumes). Indeed, a high level of microsinteny amongst the genomes of tomato, potato, pepper and eggplant was observed. Therefore, determination of the tomato genome sequence could allow extending information among species, thus creating a common map-based framework of knowledge. This could allow inferring the sequence organization of other Solanaceae crops as basis for understanding how plants diversify and adapt to new and adverse environments.

The recent release of the tomato genome sequence (Mueller et al., 2009), together with the powerful genetic and genomic resources available today for this species, allowed plant biotechnologists to implement novel methods to obtain new genotypes that could answer to new consumer, producer and processor requirements. These resources, in fact, could help the transfer of useful genes among species and/or improved genotypes through assisted breeding programs as well as through genetic transformation technologies.

In the present review, after providing some information on tomato genetic and genomic resources, we will give an overview of genetic transformation techniques and biotechnology applications investigated in this species. Several recent review reported new studies on tomato genetic transformation as a tool for the improvement of resistance to pests and pathogens (Balaji & Smart, 2011; Khan et al., 2011; Panthee & Chen, 2010; Wu et al., 2011; Zhang et al., 2010). Therefore, after a short description of main transformation techniques to which tomato is well adapted, herein we will focus on the use of genetic transformation for fruit quality engineering and pharmaceutical production.

2. Genetic and genomic resources

Among cultivated species, tomato is one of the richest in genetic and genomic resources (Table 1 and Table 2), including information now available from the complete genome sequencing that was released in the last year in a preliminary version. All these tools, used together or separately, are having a great impact on tomato breeding and genetics (Barone et al., 2009; Foolad, 2007).

This cultivated species could count on a number of wild and related species, on a wide collection of naturally or induced mutants and on many well-characterized genetic stocks, such as cultivars and landraces, cytogenetic stocks and pre-bred lines. Today this germplasm is publicly available (Table 1). In the miscellaneous group, the Backcross Recombinant Inbreds and Introgression Lines are particularly useful for the identification of genes and/or QTLs, since they constitute "immortal" population to be used for quantitative analyses (Grandillo et al., 2008). In addition, they also represent exotic libraries that allow to better exploit biodiversity exhibited by wild species. Indeed, the IL population is composed by many lines, each carrying a single homozygous genomic region from the wild species, altogether covering the whole wild genome (Eshed & Zamir, 1995; Fridman et al., 2004).

GENETIC RESOURCENOTESWEBSITE
Wild speciesMore than 1.100 accessionsTGRC (http://tgrc.ucdavis.edu),
NPGS (www.ars-usda.gov)
Monogenic mutantsMore than 600 mutantsTGRC
Miscellaneous stockMore than 1.500 accessionsTGRC, NPGS
Introgression lines (IL)from S. pennellii, S. habrochaites, S. lycopersicoidesTGRC
Backcross Recombinant Inbreds (RIL)S. lycopersicum x S. pimpinellifoliumTGRC
Induced-mutant stocksMore than 3.400 induced-mutants from cv M82SGN (http://zamir.sgn.cornell.edu/mutants)
Around 1000 induced- mutants from Micro-TomTOMATOMA (http://tomatoma.nbrp.jp)
More than 5.000 mutants from cv Red SetterLycoTill (www.agrobios.it/tilling/index.html)

Table 1.

Tomato genetic resources publicly accessible via web

Currently, IL populations that derive from various wild species are available, even though others are being generated (Barone et al., 2009). The first population (from S. pennellii) has been so far widely used to localize QTLs (Lippman et al., 2007) and to clone them (Frary et al., 2000; Fridman et al., 2000).

In addition to a collection of natural mutants available at TGRC (Tomato Genetic Resource Centre), wide collections of induced mutants were generated in different genetic backgrounds, by chemical or physical mutagenesis (Emmanuel & Levy, 2002; Menda et al., 2004; Watanabe et al., 2007). These mutants were widely phenotyped for many traits and contributed to better understand some developmental processes, such as growth habit, flowering and fruit ripening (Giovannoni, 2007; Pineda et al., 2010; Saito et al., 2011). In addition, induced mutagenesis has often been implemented with gene-specific detection of single-nucleotide mutations to generate TILLING platforms. So far, TILLING was developed for the cv. M82 (Piron et al., 2010), Red Setter (Minoia et al., 2010), Tpaadasu (Gady et al., 2009) and Micro-Tom (Saito et al., 2011) and its use has allowed the pinpointing of mutations in genes of interest.

The variability displayed by the different sources of germplasm available for tomato could be explored to search for new genes or favourable alleles to be transferred by conventional breeding and/or genetic transformation in selected genotypes to obtain new varieties.

In recent years, genetic resources combined with tomato specific genomic tools (Barone et al., 2009) allowed to successfully achieve various objectives, including the development of new varieties resistant to biotic and abiotic stresses and with improved fruit quality traits and yield. Most of these resources are also publicly available for the scientific community and are accessible via web (Table 2).

GENOMIC RESOURCENOTESWEBSITE
Molecular markersThousands markers
(i.e RFLP, AFLP, SSR, COS, CAPS, SNP)
SGN (http://solgenomics.net)
Molecular maps10 genetic maps involving crosses among different species and varietiesSGN
Physical mapfrom S. lycopersicumSGN
Complete genome sequencereleased version SL2.40 January 2011SGN
EST collectionsAround 300.000 from various tissues and developmental stagesSOLESTdb (http://biosrv.cab.unina/solestdb)
Tomato Gene Index
(http://compbio.dfci.harvard.edu/tgi), plantGDB (http://www.plantgdb.org), MiBASE (http://www.kazusa.or.jp/jsol/microtom)
transcriptomic array TOM1 (approx. 8000 unigenes)Tomato Functional Genomics database (http://ted.bti.cornell.edu)
TOM2 (approx. 11.000 independent genes)TFGD
Affimetrix (approx. 10.000 genes)(http://www.affymetrix.com)
Combimatrix TomatoArray1.0 (more than 20.000 probes)Functional Genomic Center (http://ddlab.sci.univr.it)
Metabolomic platformsMetabolites from S. pennellii and S. habrochaites ILs , metabolomics of tomato fruit from 96 cultivarsTFGD, MoToDB (http://appliedbioinformatics.wur.nl)
TILLING platformsFrom cv. Red Setter, M82LycoTill, UTill (http://urgv.evry.inra.fr/UTILLdb), (http://tilling.ucdavis.edu/index.php/TomatoTilling)
SNP arraySolCAP approx. 8000 SNPs from 6 genotypesSolCAP (http://solcap.msu.edu)
Bioinformatic platformsData mining and integration, genome annotationSGN, TFGD

Table 2.

Tomato genomic resources publicly accessible via web

Since the beginning of 1990s, the contribution of molecular markers and maps to tomato breeding and gene identification has been widely documented (Foolad, 2007; Frary et al., 2005; Gupta et al., 2009), and more than 15.000 different markers are collected in the SGN database, where markers can be searched by name, chromosome position and mapping population. Moreover, cytological and cytogenetic maps are also available, as well as a detailed physical map, which was the foundation for the tomato genome sequencing project (Mueller et al., 2005). Contemporarily, gene expression analyses performed on different tissues and developmental stages, as well as on genotypes that differ in their answer to environmental stimuli, have dramatically raised the number of ESTs available at various websites. Consequently, several microarray platforms have being designed and are being used for transcriptional profiling, thus contributing to the identification of novel genes (Baxter et al., 2005b; Di Matteo et al., 2010). In addition bioinformatics resources aiming at integrating the forthcoming tomato genome sequence, wide collections of ESTs and data from transcriptomic, proteomic and metabolomic platforms available for tomato will enhance the design and management of genetic transformation approaches, such as those pointing at fruit quality engineering and production of pharmaceutical proteins.

3. Techniques for tomato genetic transformation

Since the 1980s several Agrobacterium-mediated transformation protocols have been developed in tomato, using cotyledons or leaves (Pino et al., 2010; Sharma et al.; 2009; Van Eck et al., 2006). Transformation efficiencies obtained in various cultivars range from 10 to 41%. Many factors were believed to be crucial for tomato transformation using Agrobacterium tumefaciens, including the application of nurse cells or acetosyringone to the culture or pre-culture media, the type of explants, the Agrobacterium strain used and its concentration, co-cultivation period and the concentration of thiamine, 6-benzylamino purine (BAP), zeatin and indole acetic acid (IAA). Also, new transformation procedures have been developed for tomato varieties with low in vitro regeneration capacity (Fuentes et al., 2008) and alternative transformation methods, such as floral dip, have been tested (Yasmeen et al., 2009). In addition, novel resources for temporal and tissue-specific manipulation of gene expression in tomato plants are now available for the scientific community. In this regard, it is noteworthy the work from Fernandez et al. (2009) and Estornell et al. (2009) that created new Solanaceae genetic toolkit for targeted gene expression and silencing in tomato fruits.

Recently, as the information provided by the tomato genome sequencing become available, the demand for efficient functional genomics tools are increasing. Functional genomics studies of the tomato plant require the use of high-throughput methods for functional analysis of many genes including simple and easily reproducible plant transformation systems. The miniature tomato cultivar MicroTom is a rapid-cycling cherry tomato variety that differs from standard tomato cultivars primarily by two recessive genes that confer the dwarf genotype (Dan et al., 2006). MicroTom shares some traits with the model plant Arabidopsis thaliana such as the small size, short life cycle (70-90 days from sowing to fruit-ripening) and small genome (950 Mb) and it is therefore considered a model cultivar for tomato genetics and functional genomics. Several studies investigated the production of improved protocols for Agrobacterium-mediated MicroTom transformation obtaining a transformation efficiencies ranging from 20 to 56% (Dan et al., 2006; Qiu et al., 2007; Sun et al., 2006). Recently, Pino et al. (2010) developed an efficient and inexpensive method for MicroTom transformation using a new tomato genotype harbouring the allele Rg1 that greatly improves tomato in vitro regeneration.

Another breakthrough in the field of tomato genetic transformation was the development of a system for stable genetic transformation of tomato plastids (Ruf et al., 2001). In comparison with conventional nuclear transformation, the integration of transgenes in the plastid genome presents several advantages: 1) high expression levels of recombinant proteins attainable owing to the high ploidy level of the plastid genome (up to 10,000 plastid genomes per cell); 2) efficient transgene integration since integration into the plastid genome relies on homologous recombination between the targeting regions of the transformation vector and the wild-type plastid DNA; 3) absence of epigenetic effects (gene silencing); 4) increased biosafety due to the biological containment of transgenes and recombinant products owing to maternal inheritance of plastid and plastid transgenes and absence of dispersal in the environment through the pollen; 5) possibility to express multiple transgenes from prokaryotic-like operons, thus simplifying engineering metabolic pathways (Bock & Warzecha; Cardi et al., 2010; Ruf et al., 2001; Wurbs et al., 2007).

The availability of a technology for transgene expression from the tomato plastid genome opened up new possibilities for metabolic engineering and the use of plants as bioreactors for the production of pharmaceuticals (Ruf et al., 2001, Wurbs et al., 2007). The group of Ralph Bock investigated the possibility to elevate the pro-vitamin A content of tomatoes using the chloroplast transformation technology (Apel & Bock, 2009; Wurbs et al., 2007). Apel & Bock (2009) introduced the lycopene β-cyclase genes from the eubacterium Erwinia herbicola and the plant daffodil (Narcissus pseudonarcissus) into the tomato plastid genome in order to enhance carotenoid biosynthesis inducing lycopene-to-provitamin A conversion. The expression of the enzyme from the higher plant daffodil in fruits of transplastomic tomato plants triggered efficient conversion of lycopene to β-carotene and resulted in a >50% increase in total carotenoid accumulation. Zhou et al. (2008) studied the feasibility of producing human immunodeficiency virus (HIV) antigen in transplastomic plant and demonstrated that the HIV antigens p24 and Nef in the plastid could be expressed in plastid of tomato plants.

Today, the technology of stable plant transformation is successful in tomato; however, the lack of an efficient, simple and reliable protocol and the length of time required to produce transgenic lines complicate the analysis of gene function. In alternative, transient assays could provide a rapid tool for the functional analysis of transgenes and have been often used as an alternative to the analysis of stably transformed lines (Wroblewsky et al., 2005). A powerful tool for fast reverse genetics is the virus-induced gene silencing (VIGS) technology (Orzaez & Granell, 2009). Using this method, recombinant virus vectors carrying host-derived sequences are used to infect the plant; systemic spreading of this recombinant virus causes specific degradation of the endogenous gene transcripts by PTGS (post-transcriptional gene silencing) (Dinesh-Kumar et al., 2003; Liu et al., 2002). In 2002, Liu and colleagues demonstrated that a tobacco rattle virus (TRV)-based VIGS vector could be used in tomato to silence genes efficiently. To shorten the time and simplify the functional analysis in fruits, Orzaez et al. (2006) developed a methodology that allowed transient expression of transgenes directly in fruit tissues. However, the identification and quantification of non-visual phenotypes could be hampered by the irregular distribution of fruit VIGS. In a recent paper Orzaez et al. (2009) developed an anthocyanin-guided VIGS in order to overcome the limitations of this technique such as its irregular distribution and efficiency. To develop a visually traceable system the authors developed a method comprising: 1) a tomato line expressing Rosea1 and Delila transcription factors under the control of the E8 promoter that showed a purple-fruited phenotype and 2) a modified TRV VIGS vector incorporating partial Rosea1 and Delila sequences agro-injected in the transformed lines and that was able to restore the red-fruited phenotype.

4. Biotechnology applications

4.1. Fruit quality engineering

Tomato fruit quality includes several aspects that may be grouped into two categories: organoleptic properties and nutritious contents. Organoleptic quality involves color and texture of the fruit, but also taste and aroma, whereas nutritional quality refers to the content of metabolites contributing to the intake of nutritious such as sugars, carotenoids, flavonoids, ascorbic acid and folate.

Most of the quality traits show a continuous variation, are attributed to the joint action of many genes and are strongly induced by environmental conditions. Beside their complex inheritance, fruit quality traits have often been engineered in tomato through approaches of reverse genetics, such as genetic transformation and mutagenesis, pointing at controlling the expression of single major genes involved in the regulation of a desirable phenotype. In addition, genetic transformation has often been successful in enhancing fruit quality-related traits in tomato investigating simultaneously the role of candidate genes in specific biological processes in the fruit.

In general, there are three main goals of engineering strategies in plants (Verpoorte et al., 2000): the enhancement of a desired trait, the decrease in the expression of a specific unwanted trait, and the development of a novel trait (i.e. a molecule that is produced in nature but not usually in the host plant, or a completely novel compound). Strategies aimed at inducing changes in the expression of a trait changing the synthesis of a specific metabolite are referred to as metabolic engineering. Approaches for achieving the redirection of metabolic fluxes include the engineering of single steps in a pathway to increase or decrease metabolic flux to target compounds, to block competitive pathways or to introduce short cuts that divert metabolic flux in a particular way. However, this strategy has only limited value because the effects of modulating single enzymatic steps are often absorbed by the system in an attempt to restore homeostasis. Recently, strategies aimed at targeting multiple steps in the same pathway are gaining increasing interest because they help to control metabolic flux in a more predictable manner. This might involve up-regulating several consecutive enzymes in a pathway; up-regulating enzymes in one pathway while suppressing those in another competing pathway; or using regulatory genes such as transcription factors (TF) to establish multipoint control over one or more pathways in the cell. Since technical hurdles limits the number of genes that can be transferred to plants and pyramiding of transgenes by crossing transformants for single targets is a highly time-consuming approach, researchers developed new transformation methods to introduce multiple transgenes into plants and express them in a coordinated manner (Navqvi et al., 2009). In addition, controlling the expression of a single TF or a combination of TFs provides attractive tools for overcoming flux bottlenecks involving multiple enzymatic steps, or for deploying pathway genes in specific organs, cell types or even plants where they normally do not express.

A schematic description of successful metabolic engineering for enhancement of fruit quality in tomato is provided in Table 3 and Table 4. Genetic transformation targeting a single TF has been used to successfully engineer tomato for inducing development of parthenocarpic and seedless fruit. Parthenocarpy enables fruit set and growth to be independent from pollination, fertilization and seed development circumventing the environmental constraints on fruit production and ensuring yield stability. Seedless fruits enhance consumer appeal and could also be a valuable trait for industrial tomatoes because parthenocarpy increases the content of soluble solids, improves yield and flavour of paste and reduces processing costs. Reported applications involved the overexpression of an auxin response factor 8 (ARF8) from Arabidopsis (Goetz et al., 2007) and downregulation of Aux/IAA9 transcription factor (Wang et al., 2005) to promote fruit parthenocarpic development.

Modifications of fruit softening and of the overall firmness have been achieved mostly by engineering genes controlling single enzymatic steps in cell wall-associated pathways. In particular, polygalacturonase (Kramer et al., 1992; Langley et al. 1994; Smith et al., 1990), pectin methylesterase (Tieman & Handa, 1994), expansin (Brummell et al., 1999) and β-galactosidase (Smith et al., 2002) genes showed effectiveness in controlling fruit firmness and softening in transgenic tomato plants. A dosage series of the gene fw2.2, a negative regulator of cell division (Frary et al., 2000) was generated in tomato by genetic transformation allowing to modulate fruit weight in tomato without affecting cell size in pericarp and placenta tissues (Liu et al., 2003).

Two examples of successful metabolic engineering modifying tomato fruit flavour relayed on heterologous single-gene expression to introduce in tomato untypical traits. In the first example, a biologically active thaumatin, a sweet-tasting, flavour-enhancing protein from the African plant Thaumatococcus daniellii Benth was expressed in transgenic tomatoes that produced sweeter fruits with a specific aftertaste (Bartoszewski et al., 2003). In the second example, the lemon basil geraniol synthase (GES) gene was overexpressed under the control of the strong fruit-ripening-specific tomato polygalacturonase promoter (PG). GES encodes the enzyme responsible for the production of geraniol from GDP and its expression caused the plastidial terpenoid biosynthetic flux to divert, leading to a reduced lycopene accumulation and to dramatic changes in the aroma and overall flavour of the transgenic fruits (Davidovich-Rikanati et al., 2007).

In another study, the overexpression of either LeAADC1A or LeAADC2, encoding for phenylalanine decarboxylases that are involved in the synthesis of 2-phenylethanol from phenylalanine, resulted in fruits with up to 10-fold increased emissions of the products of the pathway, including 2-phenylacetaldehyde, 2-phenylethanol, and 1-nitro-2-phenylethane. On the other hand, antisense reduction of LeAADC2 significantly reduced emissions of these volatiles (Tieman et al., 2006).

In addition to organoleptic fruit quality, nutritional attributes of tomato fruit have recently received increasing attention by molecular biologists. For instance, the fruit soluble solid content was engineered by using an RNAi approach to generate transgenic plants that were exclusively altered in the expression of a specific isoform of the cell wall invertase LIN5 (Baxter et al., 2005a; Fridman et al., 2000, 2004; Schauer et al., 2006; Zanor et al., 2009).

Several attempts have been made also to engineer higher carotenoid contents in tomato fruit and a number of tomato lines have been generated with enhanced levels of lycopene, β-carotene and xanthophylls (mainly zeaxanthin and lutein) and low levels of non-endogenous carotenoids such as ketocarotenoids (Fraser et al., 2009). One of the most interesting achievements is the HighCaro (HC) tomato plant (D’Ambrosio et al. 2004), a transgenic line carrying the tomato lycopene β-cyclase (tLcy-b) cDNA. Carotenoid biosynthetic pathway is a highly regulated, interconnected, compartmentalized, membrane bound pathway that can be successfully engineered to enhance carotenoids in crop plants circumventing homeostasis. Carotenoids are biosynthetically related to gibberellins via geranyl-geranyl pyrophosphate and isopentenyl pyrophosphate and this often caused in transgenic plants unpredictable phenotypes. For example, in transgenic lines overexpressing the endogenous gene Psy-1, besides an effect on gibberellins formation, the levels of other isoprenoid derived phytohormones were altered in vegetative tissues as well as chlorophyll and tocopherol contents in fruit (Fray et al., 1995). In order to minimize these detrimental effects, engineering approaches to enhance carotenoids in tomato have recently focused on the use of tissue-specific promoters. The use of tomato ripening enhanced promoters allowed a controlled expression at this stage facilitating co-ordination with endogenous carotenoid formation and reducing competition with other branches of the isoprenoid pathway. On the other hand, transcriptional up-regulation of a gene does not always correlate to increased protein or enzyme activity and forward-feed regulation mechanisms could operate within the pathway to maintain homeostasis. For example, in tomato lines expressing a bacterial derived phytoene synthase (CrtB) the subsequent desaturation step in the pathway was reduced (Fraser et al., 2002). Moreover, transgenic lines expressing a bacterial desaturase had a reduced phytoene synthase transcription and enzyme activity. In addition, tomato lines overexpressing deoxy-D-xylulose 5-phosphate synthase (Dxs) showed elevated phytoene formation in ripe fruit, however desaturation limited progression through the pathway (Enfissi et al., 2005). Finally in tomato lines overexpressing Psy-1 a lycopene cyclase (CYC-B) is induced resulting in increased enzyme activity generating β-carotene as an unintended end-product (Fraser et al., 2007). By contrast, feedback inhibition could also limit accumulation of end-products as was the case of tomato lines expressing the CrtI enzyme where the elevated β-carotene levels reduced phytoene synthase (Romer et al., 2000). In contrast with results obtained in rice and potato, multiple step engineering strategies in the carotenoid and isoprenoid precursor pathways in tomato were only partially successful (Diretto et al., 2007). Finally, the simultaneous expression of an Arabidopsis LCY-B gene and a pepper CHY-B gene resulted in the production of xanthophylls, while the expression of CrtW and CrtZ from Paracoccus spp. leaded to the formation of low fruit levels of ketocarotenoids (Dharmapuri et al., 2002; Ralley et al., 2004). Innovative strategies for carotenoid engineering in tomato fruit consist in alteration of cryptochromes and components of the light signal transduction pathway. These approaches have the advantages of elevating the carotenoid content of the fruit and also other important health related phytochemicals such as phenylpropanoids and flavonoids (Davuluri et al., 2005).

Due to their presumed health benefits, there is growing interest in the development of food crops with tailor-made levels and composition of flavonoids. The repertoire of case studies aimed at increasing the levels of flavonoids in tomato fruit also offers the wider range of examples of successful engineering strategies ever realized. Herein we will list some of the results recently obtained.

The first strategy is related to engineering single structural genes controlling key steps in the pathway, such as a chalcone isomerase (CHI) (Muir et al., 2001) and a chalcone synthase (CHS) (Colliver et al., 2002). More encouraging results were obtained targeting multiple constitutive genes within the flavonoid pathway. For instance, the concomitant ectopic expression of Petunia CHS, CHI, F3H (flavanone hydroxylase) and FLS (flavonol synthase) in tomato fruit led to increased levels of flavonols in both peel (primarily quercetin glycosides) and flesh (primarily kaempferol glycosides). In another case, the concomitant expression of both CHS and FLS had a synergistic effect resulting in a significant accumulation of both naringenin- and kaempferol-glycosides in tomato flesh (Colliver et al., 2002). Secondly, in order to increase the range of flavonoids produced in tomato fruit, a different strategy was taken that consisted in introducing branches to the pathway leading to the synthesis of atypical flavonoids. The overexpression of a grape stylbene synthase (STS) resulted in the accumulation of resveratrol aglycon and its glucoside in tomato fruit peel, while the level of naringenine chalcone was negatively affected because of a competition effect with the main pathway (Schijlen et al., 2006). Similarly, the concomitant overexpression of a petunia CHS and an alfalfa chalcone reductase (CHR) allowed deoxychalcones to accumulate in the tomato peel. When a gerbera FNS-II gene and a Petunia CHI gene were simultaneous overexpressed in tomato, flavones (mainly as luteolin aglycon) accumulated in their peel (Schijlen et al., 2006). The third strategy involved engineering of transcription factors to enhance a wider range of flavonoid compounds. Besides the increased level of flavonoids induced in tomato fruit by silencing DET1, the expression in tomato of the transcription regulator AtMYB12 activated flavonol biosynthesis as well as the caffeoylquinic acid biosynthetic pathway (Adato et al., 2009). Also, a 60-fold increase in kaempferol glycosides has been achieved in tomato flesh tissue by simultaneous ectopic expression of the two maize transcription factors Lc and C1 (Bovy et al., 2002). Most surprisingly, the expression of the Delila (Del) and Rosea1 (Ros1) genes, two transcription factors from the snapdragon Antirrhinum majus, in the fruit of transgenic tomatoes induced the accumulation of high levels of anthocyanins in tomato (Butelli et al., 2008) through the activation of a broad range of flavonoid biosynthetic pathway related genes.

In contrast with flavonoid metabolism, so far a reduced number of efforts have been placed into genetic transformation-mediated metabolic engineering of tomato fruit for enhanced ascorbic acid levels. Only few of them succeeded in effectively affect ascorbic acid content and only for a limited number of structural genes within the ascorbic acid pathway. In a fruit systems biological approach, transgenic tomato lines silenced for a mitochondrial ascorbic acid synthesizing enzyme L-galactono-1,4-lactone dehydrogenase performed an increased fruit ascorbic acid level (Garcia et al., 2009) whereas the silencing of an GDP-D-mannose-3’,5’-epimerase resulted in a reduced fruit ascorbic acid accumulation (Gilbert et al., 2009). On the other hand, overexpression of GDP-D-mannose-3’,5’-epimerase genes resulted in enhances ascorbic acid accumulation in tomato fruit (Zhang et al., 2011).

Similarly to ascorbic acid, the opportunity of engineering folate accumulation in tomato fruit has been mostly overlooked and only a few attempts gave rise to successful outcomes. In order to increase pteridines, which act as folate precursors and are synthesized from p-aminobenzoate, a GTP cyclohydrolase I was overexpressed and a 2-fold increase in folate level in tomato fruit was gained (de la Garza et al., 2004). A higher folate accumulation (up to 25-fold increase) was achieved in tomato fruit by combining in the same plant the overexpression of an aminodeoxychorismate synthase, the p-aminobenzoate-forming enzyme, and the GTP cyclohydrolase I (de la Garza et al., 2007).

Comprehensively, within genetic engineering strategies for crop improvements, the most striking advances so far have involved plants engineered to produce missing nutrients or increase the level of nutrients that are already synthesized. An important trend is to move away from plants engineered to produce single nutritional compounds towards those simultaneously engineered to produce multiple nutrients, a development made possible by the increasing use of multigene engineering or regulative genetic element with pleiotropic effects.

TraitEngineering
strategy
Inserted targetFruit phenotypeReference
Partheno-carpysingle TFArf8
IAA9
induced parthenocarpyGoetz et al., 2007; Wang et al., 2005
Firmnesssingle biosynthetic key genePGreduced softeningLangley et al. 1994
PMEreduced shelf-lifeTieman and Handa, 1994
EXP1Areduced firmnessBrummell et al., 1999
β-galactosidaseincreased firmnessSmith et al., 2002
Sizedosage series of a single genefw2.2increased sizeFrary et al., 2000
Flavourheterologous single genethaumatinenhanced flavourBartoszewski et al., 2003
Flavour and aromaheterologous single gene for diverting biosynthetic fluxGESchanges in flavor & aromaDavidovich-Rikanati et al., 2007
single biosynthetic key geneLeAADC1A, LeAADC2Increased/
decreased 2-phenylacetaldehyd, 2-phenylethanol, and 1-nitro-2-phenylethane
Tieman et al., 2006

Table 3.

Examples of successful fruit engineering for organoleptic quality trait in tomato. Abbreviations: TF, transcription factor; SG, silencing; SI, serial increase of gene dosage

TraitEngineering
strategy
Inserted targetFruit phenotypeReference
Soluble solids content
single biosynthetic
key gene
Lin5reduced sugars accumulationZanor et al., 2009
Carotenoid contentsingle biosynthetic
key gene
Dxsincreased phytoene & carotenoidsEnfissi et al., 2005
CrtB, CrtI, CrtYincreased carotenoidsFraser et al., 2002, 2007; Wurbs et al., 2007
PSY-1increased carotenoidsRömer et al., 2000
CYC-B, LCY-Bincreased
lycopene & β-carotene
Rosati et al., 2000
D’Ambrosio et al., 2004; Ronen et al., 2000
genes targeting biosynthetic stepsLCY-B, CHY-Bβ-cryptoxanthin
& zeaxanthin
Dharmapuri et al., 2002
single
regulative
gene
CRY-2increased carotenoidGiliberto et al., 2005
DET-1, COP1LIKE, CUL4increased carotenoid and flavonoidLiu et al., 2004; Wang et al., 2008; Davuluri et al., 2005
FIBRILLINincreased carotenoids and volatilesSmikin et al., 2007
single biosynthetic
key gene
spermidine synthaseincreased lycopeneNeily et al., 2011
Flavonoid contentsingle biosynthetic
key gene
CHIincreased fruit peel flavonolMuir et al., 2001
genes targeting biosynthetic stepsCHS, CHI, F3H, FLSincreased flavonolsColliver et al., 2002
heterologous
gene/genes for diverting flux
STS, CHS, CHR, FNS-II, CHIaccumulation of resveratrol, deoxychalcones,
& flavones
Schijlen et al., 2006
single TFMYB12accumulation of flavonolsAdato et al., 2009
Multiple TFsDel, Ros1high levels of anthocyaninsButelli et al., 2008
Ascorbic acid contentsingle biosynthetic
key gene
GalLDH, GMEincreased/
decreased fruit ascorbic acid
Garcia et al., 2009; Gilbert et al., 2011; Zhang et al., 2011
genes targeting consecutive biosynthetic stepsGCHI and/or ADCSincreased fruit folateDiaz de la Garza et al., 2004; 2007

Table 4.

Examples of successful fruit engineering for nutritional quality traits in tomato. Abbreviations: TF, transcription factor; SG, silencing; IPP, isopenthenilpyrophosphate

4.2. Production of pharmaceutical proteins

Genetically modified plants are currently being evaluated as promising alternative for the production of recombinant proteins and antigens. Major advantages of plant-made pharmaceuticals include low cost of production, higher scale-up capacity and lack of risk of contamination with mammalian pathogens. Several antigenic proteins have been produced in plant, examples are plant-made vaccines against smallpox, HIV and HPV (Human Papilloma Virus) (Lenzi et al., 2008; Rigano et al., 2009; Scotti et al., 2009). In addition, transgenic plants can represent a suitable vehicle for oral delivery of pharmaceuticals since the plant cell wall protects the recombinant antigen in the harsh condition of stomach and intestine (Sharma et al., 2008a). The delivery of vaccines to mucosal surface makes immunization practise safe and acceptable and is capable of inducing both humoral and cell-mediated immune responses (Salyaev et al., 2010). The production of plant-made mucosal vaccines eliminates needle-associated risks and downstream processing of traditional vaccines such as purification, sterilization and refrigeration. Recently, in addition to other systems, tomato plants have been used as vehicles for the expression and oral delivery of vaccines since tomato is edible, generates abundant biomass at low cost, has flexible growth conditions and contains the natural adjuvant α-tomatine (Salyaev et al., 2010; Soria-Guerra et al., 2011). In this regards, it is noteworthy the work from Zhang and colleagues (2006) that expressed the recombinant Norwalk virus capsid protein in tomato and potato and demonstrated that, although in mice oral immunization with both dried tomato fruit and potato tuber elicited systemic and mucosal antibody responses, the recombinant vaccine in transgenic tomato fruit, especially in air-dried material, was a more potent oral immunogen than potato. The authors speculated that the robust immunogenicity of tomato-derived vaccines was due to natural bioencapsulation by the plant cell matrix and membrane systems, larger amount of smaller 23 nm Virus-like particles and the presence of the natural adjuvant α-tomatine. In this paragraph, we will describe several examples of pharmaceuticals produced in tomato plants focusing on the most recently reported studies.

Several studies reported the production of transgenic tomato plants for the expression of viral antigens. In 2008, Perea Arango and colleagues reported high-level expression of the entire coding region of the nucleoprotein (N) gene of rabies virus in transgenic tomato plants. When mice were immunized both intraperitoneally (i.p.) and orally with the tomato-made N protein, the antibody titer of mice immunized i.p. was at least four times higher than that of mice immunized orally. In addition, only mice immunized i.p. were partially protected against a peripheral virus challenge. In the same year, Pan et al. (2008) described the production of genetically modified tomato plants that expressed the structural polyprotein, P1-2A, and protease, 3C, from foot-and-mouth disease virus (FMDV). Guinea pigs vaccinated intramuscularly with foliar extracts from the transgenic material developed a virus-specific antibody response and were protected against a challenge infection. Recently, in order to develop a vaccine against HPV Paz De la Rosa et al. (2009) expressed in tomato plants chimeric particles containing the HPV 16 L1 sequence fused to a string of T-cell epitopes from HPV 16 E6 and E7 proteins. L1 fused to the string of epitopes was able to assemble into chimeric VLPs (Virus-like particles); in addition, intraperitoneal administration in mice of the transgenic material was able to induce both neutralizing antibodies against the viral particle and a cytotoxic T-lymphocytes activity against the epitopes. Up to date, several groups investigated the production of a mucosal vaccine against HIV and HBV (Hepatitis B virus) in genetically modified tomato plants (Lou et al., 2007; Salyaev et al., 2010; Zhou et al., 2008). For instance, Shchelkunov et al. (2006) investigated the production of transgenic plants expressing a synthetic chimeric gene, TBI-HBS, encoding the immunogenic ENV and GAG epitopes of HIV-1 and the surface protein antigen (HBsAg) of HBV and investigated the immunogenicity of the transgenic material fed to experimental mice. Peña Ramirez and colleagues (2007) investigated the possibility of expressing the HIV-1 Tat protein in fruits of tomato plants. In mice, oral feeding with the tomato-based vaccine was able to raise mucosal IgAs and induce serum IgGs with neutralizing activity. More recently, Cueno at al. (2010) expressed the HIV-1 protein Tat in tomato plants reaching up to 4 μg of recombinant protein per milligram plant protein. In addition, tomato extracts intradermally inoculated into mice were found to induce both humoral and cellular immune responses.

Bacterial antigens have also been expressed in transgenic tomato plants. Alvarez and colleagues (2006) expressed in transgenic tomato plants the FI-V antigen fusion protein for the production of a vaccine against pneumonic and bubonic plague. The authors tested the immunogenicity of the tomato-made vaccine in mice which were primed subcutaneously with bacterially produced F1-V and boosted orally with freeze-dried, powdered transgenic tomato fruit and demonstrated that the vaccine elicited IgG1 in serum and mucosal IgA in fecal pellets. In 2007, Soria-Guerra and collegues expressed in tomato a plant-optimized synthetic gene encoding the recombinant polypeptide sDTP (diphtheria-pertussis-tetanus), containing six DTP immunoprotective exotoxin epitopes and two adjuvants in order to develop an edible multicomponent DPT vaccine. Recently, the same group examined whether immunization of mice fed with freeze-dried tomato material elicited specific antibody responses. Sera of immunized mice tested for IgG antibody response to pertussis, tetanus and diphtheria toxin showed responses to the foreign antigens; in addition, high response of IgA against tetanus toxin was evident in gut (Soria-Guerra et al., 2011). In addition, several studies investigated the feasibility of production of a safe, inexpensive plant-based mucosal vaccine against cholera. For instance, Jang et al. (2007) expressed the Cholera toxin B subunit (CTB) in transgenic tomato fruits and demonstrated the immunogenicity of the tomato-made vaccine in mice. In alternative, Sharma and colleagues (2008b) produced the toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes P4 or P6 fused to cholera toxin B subunit (CTB) in tomato plants. In the same year, the same research group reported the production of genetically modified tomato plants for the expression of accessory colonization factor subunit A (ACFA) of Vibrio cholerae and ACFA fused to CTB (Sharma et al., 2008a).

Another advantage of using transgenic plants for the production of recombinant protein of biopharmaceutical and industrial importance is that plant cells are able to perform complex post-translational modification, including glycosylation (Agarwal et al., 2008). In this regard, the feasibility of expression of glycosylated and biologically active recombinant human (-1-antitrypsin (AAT) protein in transgenic tomato plants was demonstrated. In this study, in order to achieve high-level expression of recombinant protein in transgenic plant cells, the gene encoding human AAT protein was optimized by codon adjustment and elimination of mRNA destabilizing sequences. In addition, the synthetic gene was expressed with different signal sequences, translation initiation context sequence, Alfalfa mosaic virus UTR (untranslated region) at 5’ end and ER (endoplasmic reticulum) retention signal sequence (KDEL) at 3’ end. The modified gene driven by CaMV35S duplicated enhancer promoter resulted in high-level expression (up to 1.55% of TSP) of recombinant protein in transgenic tomato plants. Elias-Lopez et al. (2008) described the production of transgenic tomato plants expressing interleukin-12. BALB/c mice were infected with either Mycobacterium tuberculosis H37Rv strain or multi-drug-resistant clinical isolate (MDR) and treated with a daily oral dose of transgenic fruit extracts. Oral administration of the transgenic plant material improved protective immunity and induced higher resistance to mycobacterial infection, when administered the day before infection or during late progressive disease induced by virulent mycobacteria. Other therapeutic proteins produced in transgenic tomato plants include the analgesic-antitumor peptide (AGAP) from the venom of Buthus martensii Karsch (Lai et al., 2009) and human beta-amyloid for the production of a vaccine against Alzheimer`s disease (Youm et al., 2008).

Another alternative for the production of recombinant antigens in plant cells is transgene expression from the plastid genome. Chloroplast transformation offers a number of advantages, including the potential to accumulate enormous amounts of recombinant protein, uniform transgene expression rates, no gene silencing and transgene containment. Recently, Zhou et al. (2008) expressed HIV antigens p24 and Nef from tomato`s plastid genome. In tomato, antigen accumulation reached values of approximately 40% of total leaf protein. When the authors determined p24-Nef accumulation in fruits they found that although green tomatoes accumulated the HIV antigens to approximately 2.5% of the TSP, there was no expression in ripe fruits. The authors speculated that this was due to the presence in red-fruited tomatoes of chromoplasts that, compared to chloroplasts, are usually less active in plastid gene expression.

Up to date, several studies demonstrated the feasibility of using tomato plants as vehicles for the production of pharmaceuticals. One drawback of a tomato-made vaccine could be the short shelf-life of fresh fruits. To provide antigen stability during storage, food-processing techniques, such as freeze-drying, could be applied to transgenic tomato fruits expressing recombinant proteins. Freeze-dried plant material could be stored for long time and consumed without cooking; in addition, this technique could allow to standardize and concentrate the plant-made vaccine. Several studies applied this technique to vaccine produced in transgenic tomato and demonstrated that freeze-dried produced stable formulations for oral delivery (Alvarez et al., 2006; Salyaev et al., 2010; Shchelkunov et al., 2006; Soria-Guerra et al., 2011; Zhang et al., 2006).

5. Conclusion

In the present review, we underlined the role of genetic transformation as method to improve fruit quality and pharmaceutical production. In addition, we highlighted the double role of genetic transformation as tool for biotechnology applications and functional analyses of genes of interest (Figure 1). For tomato, these approaches are feasible following strategies of gene/QTL identification based on the use of genetic and genomic resources today available for this species.

Nowadays, European politicians often debate about perceived risks of genetically modified crops, while ignoring potential benefits; therefore, it is highly unlikely that engineered crops will be adopted in the short-to-medium term.

Considering these constraints, mutants could be envisaged as valid alternative to engineer tomato plants for enhanced fruit quality (Figure 1). Mutants could be selected from natural variation or generated using different approaches. In addition, if the mutant exhibits superior alleles, it could be used as improved genotypes or as donor parent in backcrossing breeding schemes to deliver the desirable trait. The isogenic mutant resources available today for tomato are useful for dissecting the mechanisms underlying mutant phenotypes, and such mutagenized populations are also being used to develop targeting induced local lesions in genomes (TILLING) platforms, which represent a high-throughput genetic strategy to screen for point mutations in specific regions of targeted genes, and to validate gene function (McCallum et al., 2000).

media/image2.jpeg

Figure 1.

Flow-Chart of steps from the screening of genetic and genomic resources to improved tomato lines

Another alternative approach to obtain tomato with desirable traits is to discover gene markers that discriminate contrasting alleles in genes or QTLs that control the trait(s) of interest (Figure 1). Following their identification, useful genes or QTLs can be introgressed into desirable genetic backgrounds via Marker Assisted Selection (MAS), where the selection for a trait is based on the genotype rather that the trait itself (Foolad, 2007). The knowledge of the tomato genome sequence dramatically enhances identification of novel molecular markers. Indeed we can envisage that, notwithstanding the implementation of recently developed Next Generation Sequencing technologies, the routine application of markers in tomato breeding will increase (Varshney et al., 2009).

In conclusion, the use of different approaches, such as tomato genetic transformation, exploiting of mutants and identification of allele-specific markers, could not only speed up the process of gene transfer, but it could also allow pyramiding of desirable genes and QTLs from different genetic backgrounds. The rapid integration of new alleles in elite tomato lines will allow new cultivars with desirable traits to enter the market in a shorter time compared to cultivar obtained through traditional breeding.

Acknowledgements

Contribution no.Book 007 from the DISSPAPA

References

1 - A. Adato, T. Mandel, S. Mintz-Oron, I. Venger, D. Levy, M. Yativ, E. Dominguez, Z. Wang, R. C. De Vos, R. Jetter, L. Schreiber, A. Heredia, I. Rogachev, A. Aharoni, 2009Fruit-surface flavonoid accumulation in tomato is controlled by a SlMYB12-regulated transcriptional network. PLoS Genetics, 512e1000777
2 - S. Agarwal, R. Singh, I. Sanyal, D. V. Amla, 2008Expression of modified gene encoding functional human α-1-antitrypsin protein in transgenic tomato plants. Transgenic Research, 17881896
3 - M. L. Alvarez, H. L. Pinyeard, J. D. Crisantes, M. M. Rigano, J. Pinkhasov, A. M. Walsmley, H. S. Mason, G. A. Cardineau, 2006Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice. Vaccine, 2424772490
4 - W. Apel, R. Bock, 2009Enhancement of carotenoid biosynthesis in transplastomic tomatoes by induced lycopene-to-provitamin A conversion. Plant Physiology, 1515966
5 - Y. Bai, P. Lindhout, 2007Domestication and Breeding of Tomatoes: What have We Gained and What Can We Gain in the Future? Annals of Botany, 10010851094
6 - V. Balaji, C. D. Smart, 2011Over-expression of snakin-2 and extensin-like protein genes restricts pathogen invasiveness and enhances tolerance to Clavibacter michiganensis subsp. michiganensis in transgenic tomato (Solanum lycopersicum). Transgenic Research, doi:10.1007/s11248-011-9506-x
7 - A. Barone, M. L. Chiusano, M. R. Ercolano, G. Giuliano, S. Grandillo, L. Frusciante, 2008Structural and functional genomics of tomato. International Journal Plant Genomics, doi:10.1155/2008/820274
8 - A. Barone, A. Di Matteo, D. Carputo, L. Frusciante, 2009High-throughput genomics enhances tomato breeding efficiency. Current Genomics, 10119
9 - G. Bartoszewski, A. Niedziela, M. Szwacka, K. Niemirowicz-Szczytt, 2003Modification of tomato taste in transgenic plants carrying a thaumatin gene from Thaumatococcus daniellii Benth. Plant Breeding, 1224347351
10 - C. J. Baxter, F. Carrari, A. Bauke, S. Overy, S. A. Hill, P. W. Quick, A. R. Fernie, L. J. Sweetlove, 2005aFruit carbohydrate metabolism in an introgression line of tomato with increased fruit soluble solids. Plant Cell Physiology, 46425437
11 - C. J. Baxter, M. Sabar, W. P. Quick, L. J. Sweetlove, 2005bComparison of changes in fruit gene expression in tomato introgression lines provides evidence of genome-wide transcriptional changes and reveals links to mapped QTLs and described traits. Journal of Experimental Botany, 5615911604
12 - R. Bock, H. Warzecha, 2010Solar-powered factories for new vaccines and antibiotics. Trends in Biotechnology, 28Issue 5246252
13 - A. Bovy, R. de Vos, M. Kemper, E. Schijlen, M. A. Pertejo, S. Muir, G. Collins, S. Robinson, M. Verhoeyen, S. Hughes, C. Santos-Buelga, A. van Tunen, 2002High flavonol tomatoes resulting from the heterologous expression of the maize transcription factor genes Lc and C1. Plant Cell, 1425092526
14 - D. A. Brummell, M. H. Harpster, P. M. Civello, J. M. Palys, A. B. Bennett, P. Dunsmuir, 1999Modification of Expansin Protein Abundance in Tomato Fruit Alters Softening and Cell Wall Polymer Metabolism during Ripening. The Plant Cell, 1122032216
15 - E. Butelli, L. Titta, M. Giorgio, H. P. Mock, A. Matros, S. Peterek, E. G. Schijlen, R. D. Hall, A. G. Bovy, J. Luo, C. Martin, 2008Enrichment of tomato fruit with health-promoting anthocyanins by expression of select transcription factors. Nature Biotechnology,2613011308
16 - T. Cardi, P. Lenzi, P. Maliga, 2010Chloroplasts as expression platforms for plant-produced vaccines. Expert Review of Vaccines, 9Issue 8893911
17 - H. Chen, M. Chang, B. Chiang, S. Jeng, 2006Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine, 2429442951
18 - S. Colliver, A. Bovy, G. Collins, S. Muir, S. Robinson, C. H. R. de Vos, M. E. Verhoeyen, 2002Improving the nutritional content of tomatoes through reprogramming their flavonoid biosynthetic pathway. Phytochemistry Reviews, 1113123
19 - M. E. Cueno, Y. Hibi, K. Karamatsu, Y. Yasutomi, K. Imai, A. C. Laurena, T. Okamoto, 2010Preferential expression and immunogenicity of HIV-1 Tat fusion protein expressed in tomato plant. Transgenic Research,19889895
20 - C. D’Ambrosio, G. Giorio, I. Marino, A. Merendino, A. Petrozza, L. Salfi, A. L. Stigliani, F. Cellini, 2004Virtually complete conversion of lycopene into β-carotene in fruits of tomato plants transformed with the tomato lycopene β-cyclase (tlcy-b) cDNA. Plant Science, 166207214
21 - Y. Dan, H. Yan, T. Munyikw, J. Dong, Y. Zhang, C. L. Armstrong, 2006MicroTom- a high-throughput model transformation system for functional genomics. Plant Cell Reports, 25432441
22 - R. Davidovich-Rikanati, Y. Sitrit, Y. Tadmor, Y. Iijima, N. Bilenko, E. Bar, B. Carmona, E. Fallik, N. Dudai, J. E. Simon, E. Pichersky, E. Lewinsohn, 2007Enrichment of tomato flavor by diversion of the early plastidial terpenoid pathway. Nature Biotechnology, 25899901
23 - G. R. Davuluri, A. van Tuinen, P. D. Fraser, A. Manfredonia, R. Newman, D. Burgess, D. A. Brummell, S. R. King, J. Palys, J. Uhlig, P. M. Bramley, H. M. Pennings, C. Bowler, 2005Fruit-specific RNAi-mediated suppression of DET1 enhances carotenoid and flavonoid content in tomatoes. Nature Biotechnology, 23890895
24 - R. I. D. de la Garza, J. F. Gregory, A. D. Hanson, 2007Folate biofortification of tomato fruit. Proceedings of the National Academy of Sciences of the United States of America, 1041042184222
25 - R. I. D. de la Garza, R. Quinlivan, E. P. Klaus, S. M. Basset, G. J. Gregory, A. D. Hanson, 2004Folate biofortification in tomatoes by engineering the pteridine branch of folate synthesis. Proceedings of the National Academy of Sciences of the United States of America, 1011372013725
26 - S. Dharmapuri, C. Rosati, P. Pallara, R. Aquilani, F. Bouvier, B. Camara, G. Giuliano, 2002Metabolic engineering of xanthophyll content in tomato fruits. FEBS Letters, 5193034
27 - A. Di Matteo, A. Sacco, M. Anacleria, M. Pezzotti, M. Delledonne, A. Ferrarini, L. Frusciante, A. Barone, 2010The ascorbic acid content of tomato fruits is associated with the expression of genes involved in pectin degradation. BMC Plant Biology, 10163173
28 - S. P. Dinesh-Kumar, R. Anandalakshmi, R. Marathe, M. Schiff, Y. Liu, 2003Virus-Induced gene silencing. Methods in Molecular Biology, 236287294
29 - G. Diretto, S. Al-Babili, R. Tavazza, V. Papacchioli, P. Beyer, G. Giuliano, 2007Metabolic engineering of potato carotenoid content through tuber-specific overexpression of a bacterial mini-pathway. PLoS ONE, 2e350
30 - A. L. Elías-López, B. Marquina, A. Gutiérrez-Ortega, D. Aguilar, M. Gomez-Lim, R. Hernández-Pando, 2008Transgenic tomato expressing interleukin-12 has a therapeutic effect in a murine model of progressive pulmonary tuberculosis. Clinical and Experimental Immunology, 154123133
31 - E. Emmanuel, A. A. Levy, 2002Tomato mutants as tools for functional genomics. Current Opinion in Plant Biology, 5112117
32 - E. M. A. Enfissi, P. D. Fraser, L. M. Lois, A. Boronat, W. Schuch, Bramley, P. M. , 2005Metabolic engineering of the mevalonate and non-mevalonate isopentenyl diphosphate-forming pathways for the production of health-promoting isoprenoids. Plant Biotechnology Journal, 31727
33 - Y. Eshed, D. Zamir, 1995An introgression line population of Lycopersicon pennellii in the cultivated tomato enables the identification and fine mapping of yield-associated QTL. Genetics, 14111471162
34 - L. H. Estornell, D. Orzaez, L. Lopez-Pena, B. Pineda, M. T. Anton, V. Moreno, A. Granell, 2009A multisite gateway-based toolkit for targeted gene expression and hairpin RNA silencing in tomato fruits. Plant Biotechnology Journal, 7298309
35 - A. I. Fernandez, N. Viron, M. Alhagdow, M. Karimi, M. Jones, Z. Amsellem, A. Sicard, A. Czerednik, G. Angenent, D. Grierson, S. May, G. Seymour, Y. Eshed, M. Lemaire-Chamkey, C. Rothan, P. Hilson, 2009Flexible tools for gene expression and silencing in tomato. Plant Physiology, 15117291740
36 - M. R. Foolad, 2007Genome Mapping and Molecular Breeding of Tomato. International Journal of Plant Genomics, doi:10.1155/2007/64358
37 - A. Frary, T. C. Nesbitt, S. Grandillo, E. van der Knaap, B. Cong, J. Liu, J. Meller, R. Elber, K. B. Alpert, S. D. Tanksley, 2000fw2.2: A Quantitative Trait Locus Key to the Evolution of Tomato Fruit Size. Science, 28954768588
38 - A. Frary, Y. Xu, J. Liu, et al.2005Development of a set of PCR-based anchor markers encompassing the tomato genome and evaluation of their usefulness for genetics and breeding experiments. Theoretical and Applied Genetics, 1112291312
39 - P. D. Fraser, E. M. Enfissi, P. M. Bramley, 2009Genetic engineering of carotenoid formation in tomato fruit and the potential application of systems and synthetic biology approaches. Archives of Biochemistry and Biophysics, 483196204
40 - P. D. Fraser, E. M. Enfissi, J. M. Halket, M. R. Truesdale, D. Yu, C. Gerrish, P. M. Bramley, 2007Manipulation of phytoene levels in tomato fruit: effects on isoprenoids, plastids, and intermediary metabolism. Plant Cell, 1931943211
41 - P. D. Fraser, S. Roemer, C. A. Shipton, P. B. Mills, J. W. Kiano, N. Misawa, R. G. Drake, W. Schuch, P. M. Bramley, 2002Evaluation of transgenic tomato plants expressing an additional phytoene synthase in a fruit-specific manner. Proceedings of the National Academy of Sciences of the United States of America, 9910921097
42 - R. G. Fray, A. Wallace, P. D. Fraser, D. Valero, P. Hedden, P. M. Bramley, D. Grierson, 1995Constitutive expression of a fruit phytoene synthase gene in transgenic tomatoes causes dwarfism by redirecting metabolites from the gibberellin pathway. Plant Journal, 8693701
43 - E. Fridman, F. Carrari, Y. S. Liu, A. R. Fernie, D. Zamir, 2004Zooming in on a quantitative trait for tomato yield using interspecific introgressions. Science, 30517861789
44 - E. Fridman, T. Pleban, D. Zamir, 2000A recombination hotspot delimits a wild-species quantitative trait locus for tomato sugar content to 484 bp within an invertase gene. Proceedings of the National Academy of Sciences of the United States of America, 9747184723
45 - A. D. Fuentes, P. L. Ramos, Y. Sanchez, D. Callard, A. Ferreira, K. Tiel, K. Cobas, R. Rodriguez, C. Borroto, V. Doreste, M. Pujol, 2008A transformation procedure for recalcitrant tomato by addressing transgenic plant-recovery limiting factors. Biotechnology Journal, 310881093
46 - A. L. F. Gady, F. W. K. Hermans, M. Van de Wal, H. B. J.; van Loo, E. N.; Visser, R. G. F. & Bachem, C. W. B. (2009Implementation of two high through-put tech- niques in a novel application: detecting point mutations in large EMS mutated plant populations. Plant Methods, 5114
47 - V. Garcia, R. Stevens, L. Gil, L. Gilbert, N. Gest, J. Petit, M. Faurobert, M. Maucourt, C. Deborde, A. Moing, J. L. Poessel, D. Jacob, J. P. Bouchet, J. L. Giraudel, B. Gouble, D. Page, M. Alhagdow, C. Massot, H. Gautier, M. Lemaire-Chamley, D. Rolin, B. Usadel, M. Lahaye, M. Causse, P. Baldet, C. Rothan, 2009An integrative genomics approach for deciphering the complex interactions between ascorbate metabolism and fruit growth and composition in tomato. Comptes Rendus Biologies, 33210071021
48 - L. Gilbert, M. Alhagdow, A. Nunes-Nesi, B. Quemener, F. Guillon, B. Bouchet, M. Faurobert, B. Gouble, D. Page, V. Garcia, J. Petit, R. Stevens, M. Causse, A. R. Fernie, M. Lahaye, C. Rothan, P. Baldet, 2009GDP-D-mannose 3,5-epimerase (GME) plays a key role at the intersection of ascorbate and non-cellulosic cell-wall biosynthesis in tomato. The Plant Journal, 60499508
49 - L. Giliberto, G. Perrotta, P. Pallara, J. L. Weller, P. D. Fraser, P. M. Bramley, A. Fiore, M. Tavazza, G. Giuliano, 2005Manipulation of the Blue Light Photoreceptor Cryptochrome 2 in Tomato Affects Vegetative Development, Flowering Time, and Fruit Antioxidant Content. Plant Physiology, 137199208
50 - J. J. Giovannoni, 2007Fruit ripening mutants yield insights into ripening control. Current Opinion in Plant Biology, 103283289
51 - M. Goetz, L. C. Hooper, S. D. Johnson, J. C. Rodrigues, A. Vivian-Smith, A. M. Koltunow, 2007Expression of aberrant forms of AUXIN RESPONSE FACTOR8 stimulates parthenocarpy in Arabidopsis and tomato. Plant Physiology, 145351366
52 - S. Grandillo, S. D. Tanksley, D. Zamir, 2008Exploitation of natural biodiversity through genomics, In Genomics Assisted Crop Improvement: Vol I Genomics Approaches and Platforms (R.K. Varshney & R. Tuberosa Ed.) Springer, The Netherlands: 121150
53 - V. Gupta, S. Mathur, A. U. Solanke, M. K. Sharma, R. Kumar, S. Vyas, P. Khurana, J. P. Khurana, A. K. Tyagi, A. K. Sharma, 2009Genome analysis and genetic enhancement of tomato. Critical Reviews in Biotechnology, 292152181
54 - A. Gur, D. Zamir, 2004Unused natural variation can lift yield barriers in plant breeding. PLoS Biology,210e245
55 - X. Jang, Z. He, Z. Peng, Y. Qi, Q. Chen, S. Yu, 2007Cholera toxin B protein in transgenic tomato fruit induces systemic immune response in mice. Transgenic Research, 16169175
56 - R. S. Khan, I. Nakamura, M. Mii, 2011Development of disease-resistant marker-free tomato by R/RS site-specific recombination. Plant Cell Reports, doi:10.1007/s00299-011-1011-4
57 - M. Kramer, R. Sanders, H. Bolkan, C. Waters, R. E. Sheeny, W. R. Hiatt, 1992Postharvest evaluation of transgenic tomatoes with reduced levels of polygalacturonase: processing, firmness and disease resistance. Postharvest Biology and Technology, 13241255
58 - L. Lai, T. Huang, Y. Wang, Y. Liu, J. Zhang, Y. Song, 2009The expression of analgesic-antitumor peptide (AGAP) from Chinese Buthus martensii Karsch in transgenic tobacco and tomato. Molecular Biology Reports, 3610331039
59 - K. R. Langley, A. Martin, R. Stenning, A. J. Murray, G. E. Hobson, W. W. Schuch, C. R. Bird, 1994Mechanical and optical assessment of the ripening of tomato fruit with reduced polygalacturonase activity. Journal of the Science of Food and Agriculture, 664547554
60 - P. Lenzi, N. Scotti, F. Alagna, M. L. Tornesello, A. Pompa, A. Vitale, A. De Stradis, L. Monti, S. Grillo, F. M. Buonaguro, P. Maliga, T. Cardi, 2008Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. Transgenic Research, 17Issue 610911102
61 - Z. B. Lippman, Y. Semel, D. Zamir, 2007An integrated view of quantitative trait variation using tomato interspecific introgression lines. Current Opinion in Genetics & Development, 17545552
62 - J. Liu, B. Cong, S. D. Tanksley, 2003Generation and analysis of an artificial gene dosage series in tomato to study the mechanisms by which the cloned quantitative trait locus fw2.2 controls fruit size. Plant Physiology, 132292299
63 - Y. Liu, S. Roof, Z. Ye, C. Barry, A. van Tuinen, J. Vrebalov, C. Bowler, J. Giovannoni, 2004Manipulation of light signal transduction as a means of modifying fruit nutritional quality in tomato. Proceedings of the National Academy of Sciences of the United States of America, 10198979902
64 - Y. Liu, M. Schiff, S. P. Dinesh-Kumar, 2002Virus-Induced gene silencing in tomato. The Plant Journal, 31Issue 6777786
65 - X. Lou, Q. Yao, Z. Zhang, R. Peng, A. Xiong, H. Wang, 2007Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants. Clinical and Vaccine Immunology, 14Issue 4464469
66 - C. M. Mc Callum, L. Comai, E. A. Greene, S. Henikoff, 2000Targeting induced local lesions in genomes (TILLING) for plant functional genomics. Plant Physiology, 123439442
67 - N. Menda, Y. Semel, D. Peled, Y. Eshed, D. Zamir, 2004In silico screening of a saturated mutation library of tomato. Plant Journal, 385861872
68 - S. Minoia, A. Petrozza, O. D’Onofrio, F. Piron, G. Mosca, G. Sozio, F. Cellini, A. Bendahmane, F. Carriero, 2010A new mutant genetic resource for tomato crop improvement by TILLING technology. BMC Research Notes, 369
69 - L. A. Mueller, R. K. Lankhorst, S. D. Tanksley, et al.2009A Snapshot of the Emerging Tomato Genome Sequence. The Plant Genome, 217892
70 - L. A. Mueller, S. D. Tanksley, J. J. Giovannoni, et al.2005The Tomato Sequencing Project, the first cornerstone of the International Solanaceae Project (SOL). Comparative and Functional Genomics, 63153158
71 - S. R. Muir, G. J. Collins, S. Robinson, S. G. Hughes, A. G. Bovy, C. H. de Vos, A. J. van Tunen, M. E. Verhoeyen, 2001Overexpression of petunia chalcone isomerase in tomato results in fruit containing dramatically increased levels of flavonols. Nature Biotechnology, 19470474
72 - S. Naqvi, G. Farré, G. Sanahuja, T. Capell, C. Zhu, P. Christou, 2009When more is better: multigene engineering in plants. Trends in Plant Science, 1514856
73 - M. H. Neily, C. Matsukura, M. Maucourt, S. Bernillon, C. Deborde, A. Moing, Y. Yin, G. , T. Saito, K. Mori, E. Asamizu, D. Rolin, T. Moriguchi, H. Ezura, 2011Enhanced polyamine accumulation alters carotenoid metabolism at the transcriptional level in tomato fruit over-expressing spermidine synthase. Journal of Plant Physiology, 1683242252
74 - D. Orzaez, A. Granell, 2009Reverse genetics and transient gene expression in fleshy fruits. Plant Signaling and Behaviour, 4Issue 9864886
75 - D. Orzaez, A. Medina, S. Torre, J. P. Fernandez-Moreno, J. L. Rambla, A. Fernandez-del-Carmen, E. Butelli, C. Martin, A. Granell, 2009A visual-reporter system for virus-induced gene silencing in tomato fruit based on anthocyanin accumulation. Plant Physiology, 1501122
76 - D. Orzaez, S. Mirabel, W. H. Wieland, A. Granell, 2006Agroinjection of tomato fruits. A tool for rapid functional analysis of transgenes directly in fruit. Plant Physiology, 140311
77 - L. Pan, Y. Zhang, Y. Wang, B. Wang, W. Wang, Y. Fang, S. Jiang, J. Lv, W. Wang, Y. Sun, Q. Xie, 2008Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1-2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs. Veterinary Immunology and Immunopathology, 1218390
78 - D. R. Panthee, F. Chen, 2010Genomics of Fungal Disease Resistance in Tomato. Current Genomics, 311301389-2029
79 - Rosa. G. Paz la, A. Monroy-Garcia, Mora. de Lourdes-Garcia, M. , Peña. C. G. Reynaga, J. Hernández-Montes, B. Weiss-Steider, Lim. A. M. Gómez, 2009An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice. Virology Journal, 62
80 - Ramírez. Y. J. Peña, E. Tasciotti, A. Gutierrez-Ortega, Torres. A. J. Donayre, Flores. M. T. Olivera, M. Giacca, Lim. M. A. Gómez, 2007Fruit-specific expression of the human immunodeficiency virus type 1 tat gene in tomato plants and its immunogenic potential in mice. Clinical and Vaccine Immunology, 14685692
81 - Arango. I. Perea, Rubio. E. Loza, Anaya. E. Rojas, Flores. T. Olivera, Vara. Gonzalez la, Gomez Lim, M.A. (2008Expression of the rabies virus nucleoprotein in plants at high-levels and evaluation of immune responses in mice. Plant Cell Reports, 27677685
82 - B. Pineda, E. Gimenez-Caminero, B. Garcia-Sogo, M. T. Anton, A. Atares, J. Capel, et al.2010Genetic and physiological charac- terization of the arlequin insertional mutant reveals a key regulator of reproductive development in tomato. Plant Cell Physiology, 51435447
83 - L. E. Pino, S. Lombardi-Crestana, M. S. Azevedo, D. C. Scotton, L. Borgo, V. Quecini, A. Figueira, L. E. P. Peres, 2010The Rg1 allele as a valuable tool for genetic transformation of the tomato “Micro-Tom” model system. Plant Methods, 623
84 - F. Piron, M. Nicolai, S. Minoia, E. Piednoir, A. Moretti, A. Salgues, D. Zamir, C. Caranta, A. Bendahmane, 2010An induced mutation in tomato eIF4E leads to immunity to two potyviruses. PLoS One, 56e11313
85 - D. Qiu, G. Diretto, R. Tavarza, G. Giuliano, 2007Improved protocol for Agrobacterium mediated transformation of tomato and production of transgenic plants containing carotenoid biosynthetic gene CsZCD. Scientia Horticulturae, 112172175
86 - L. Ralley, E. M. Enfissi, N. Misawa, W. Schuch, P. M. Bramley, P. D. Fraser, 2004Metabolic engineering of ketocarotenoid formation in higher plants. Plant Journal, 39477486
87 - D. Rein, E. Schijlen, T. Kooistra, K. Herbers, L. Verschuren, R. Hall, U. Sonnewald, A. Bovy, R. Kleemann, 2006Transgenic flavonoid tomato intake reduces C- reactive protein in human C-reactive protein transgenic mice more than wild-type tomato. Jouirnal of Nutrition, 13623312337
88 - M. M. Rigano, C. Manna, A. Giulini, E. Pedrazzini, M. Capobianchi, C. Castilletti, A. Di Caro, G. Ippolito, P. Beggio, Morghen. C. De Giuli, L. Monti, A. Vitale, T. Cardi, (2009, 2009Transgenic chloroplasts are efficient sites for high-yield production of the vaccinia virus envelope protein A27L in plant cells. Plant Biotechnology Journal, 7Issue 6577591
89 - S. Römer, P. D. Fraser, J. W. Kiano, C. A. Shipton, P. B. Mills, R. Drake, W. Schuch, P. M. Bramley, 2000Elevation of the provitamin A content of transgenic tomato plants. Nature Biotechnology, 18666669
90 - G. Ronen, L. Carmel-Goren, D. Zamir, J. Hirschberg, 2000An alternative pathway to β-carotene formation in plant chromoplasts discovered by map-based cloning of beta and old-gold color mutations in tomato. Proceedings of the National Academy of Sciences of the United States of America, 971110211107
91 - C. Rosati, R. Aquilani, S. Dharmapuri, P. Pallara, C. Marusic, R. Tavazza, F. Bouvier, B. Camara, G. Giuliano, 2000Metabolic engineering of β-carotene and lycopene content in tomato fruit. Plant Journal, 24413420
92 - S. Ruf, M. Hermann, I. J. Berger, H. Carrer, R. Bock, 2001Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit. Nature Biotechnology, 19870875
93 - T. Saito, T. Ariizumi, Y. Okabe, E. Asamizu, K. Hiwasa-Tanase, N. Fukuda, T. Mizoguchi, Y. Yamazaki, K. Aoki, H. Ezura, 2011TOMATOMA: A Novel Tomato Mutant Database Distributing Micro-Tom Mutant Collections. Plant and Cell Physiology, 522283296
94 - R. K. Salyaev, M. M. Rigano, N. I. Rekoslavskaya, 2010Development of plant-based mucosal vaccines against widespread infectious diseases. Expert Reviews of Vaccines, 9Issue 8937946
95 - N. Schauer, Y. Semel, U. Roessner, A. Gur, I. Balbo, F. Carrari, T. Pleban, A. Perez-Melis, C. Bruedigam, J. Kopka, L. Willmitzer, D. Zamir, A. R. Fernie, 2006Comprehensive metabolic profiling and phenotyping of interspecific introgression lines for tomato improvement. Nature Biotechnology, 24447454
96 - E. Schijlen, C. H. R. de Vos, H. Jonker, Broeck. H. van den, J. Molthoff, A. van Tunen, S. Martens, A. Bovy, 2006Pathway engineering for healthy phytochemicals leading to the production of novel flavonoids in tomato fruit. Plant Biotechnology Journal, 4433444
97 - N. Scotti, F. Alagna, E. Ferraiolo, G. Formisano, L. Sannino, L. Buonaguro, A. De Stradis, A. Vitale, L. Monti, S. Grillo, F. M. Buonaguro, T. Cardi, 2009High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts. Planta, 229Issue 511091122
98 - M. K. Sharma, D. Jani, M. Thungapathra, J. K. Gautam, L. S. Meena, Y. Singh, A. Ghosh, A. K. Tyagi, A. K. Sharma, 2008aExpression of accessory colonization factor subunit A (ACFA) of Vibrio cholerae and ACFA fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). Journal of Biotechnology, 1352227
99 - M. K. Sharma, N. K. Singh, D. Jani, R. Sisodia, M. Thungapathra, J. K. Gautam, L. S. Meena, Y. Singh, A. Ghosh, A. K. Tyagi, A. K. Sharma, 2008bExpression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). Plant Cell Reports, 27307318
100 - M. K. Sharma, A. U. Solanke, D. Jani, Y. Singh, A. K. Sharma, 2009A simple and efficient Agrobacterium-mediated procedure for transformation of tomato. Journal of Biosciences, 34Issue 3423433
101 - S. N. Shchelkunov, R. K. Salyaev, S. G. Posdnyakov, N. I. Rekoslavskaya, A. E. Nesterov, T. S. Ryzhova, V. M. Sumtsova, N. V. Pakova, U. O. Mishutina, T. V. Kopytina, R. W. Hammond, 2006Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses. Biotechnology Letters, 28959967
102 - A. J. Simkin, J. Gaffé, J. P. Alcaraz, J. P. Carde, P. M. Bramley, P. D. Fraser, M. Kuntz, 2007Fibrillin influence on plastid ultrastructure and pigment content in tomato fruit. Phytochemistry, 681115451556
103 - C. J. S. Smith, C. F. Watson, C. R. Bird, J. Ray, W. Schuch, D. Grierson, 1990Expression of a truncated tomato polygalacturonase gene inhibits expression of the endogenous gene in transgenic plants. Molecular and General Genetics, 2243477481
104 - D. L. Smith, J. A. Abbott, K. C. Gross, 2002Down-regulation of tomato beta-galactosidase 4 results in decreased fruit softening. Plant Physiology, 12917551762
105 - R. E. Soria-Guerra, S. Rosales-Mendoza, C. Márquez-Mercado, R. López-Revilla, R. Castilli-Collazo, A. G. Alpuche-Solís, 2007Transgenic tomatoes express an antigenic polypeptide containing epitopes of the diphtheria, pertussis and tetanus exotoxins, encoded by a synthetic gene. Plant Cell Reports, 26961968
106 - R. E. Soria-Guerra, S. Rosales-Mendoza, L. Moreno-Fierros, R. López-Revilla, A. G. Alpuche-Solís, 2011Oral immunogenicity of tomato derived sDPT polypeptide containing Corynebacterium diphteriae, Bordetella pertussis and Clostridium tetani exotoxin epitopes. Plant Cell Reports, 30417424
107 - H. Sun, S. Uchii, S. Watanabe, H. Ezura, 2006A highly efficient transformation protocol for Micro-Tom, a model cultivar for tomato functional genomics. Plant and Cell Physiology, 47Issue 3426431
108 - D. M. Tieman, A. K. Handa, 1994Reduction in pectin methyltransferase activity modifies tissue integrity and cation levels in ripening tomato (Lycopersicon esculentum Mill.) fruits. Plant Physiology, 106429436
109 - D. M. Tieman, M. Zeigler, E. A. Schmelz, M. G. Taylor, P. Bliss, M. Kirst, H. J. Klee, 2006Identification of loci affecting flavour volatile emissions in tomato fruits. Journal of Experimental Botany, 57887896
110 - J. Van Eck, D. D. Kirk, A. M. Walsmley, 2006Tomato (Lycopersicum esculentum). Methods in Molecular Biology, 3434594773
111 - R. K. Varshney, S. N. Nayak, G. D. May, S. A. Jackson, 2009Next-generation sequencing technologies and their implications for crop genetics and breeding. Trends in Biotechnology, 279522530
112 - R. Verpoorte, R. van der Heijdenvan, J. Memelink, 2000Engineering the plant cell factory for secondary metabolite production. Transgenic Research, 9323343
113 - H. Wang, B. Jones, Z. Li, P. Frasse, C. Delalande, F. Regad, S. Chaabouni, A. Latche, J. C. Pech, M. Bouzayen, 2005The tomato Aux/IAA transcription factor IAA9 is involved in fruit development and leaf morphogenesis. Plant Cell, 1726762692
114 - S. Wang, J. Liu, Y. Feng, X. Niu, J. Giovannoni, Y. Liu, 2008Altered plastid levels and potential for improved fruit nutrient content by downregulation of the tomato DDB1-interacting protein CUL4. The Plant Journal, 55189103
115 - S. Watanabe, T. Mizoguchi, K. Aoki, Y. Kubo, H. Mori, S. Imanishi, Y. Yamazaki, D. Shibata, H. Ezura, 2007Ethylmethanesulfonate (EMS) mutagenesis of Solanum lycopersicum cv. Micro-Tom for large-scale mutant screens. Plant Biotechnology, 243338
116 - T. Wroblewski, A. Tomczak, R. Michelmore, 2005Optimization of Agrobacterium-mediated transient assays of gene expression in lettuce, tomato and Arabidopsis. Plant Biotechnology Journal, 3259273
117 - F. Wu, S. D. Tanksley, 2010Chromosomal evolution in the plant family Solanaceae. BMC Genomics, 1711182
118 - Y. Wu, Y. He, X. Ge, 2011Functional characterization of the recombinant antimicrobial peptide Trx-Ace-AMP1 and its application on the control of tomato early blight disease. Applied Microbiology and Biotechnology, doi:10.1007/s00253-011-3166-x
119 - D. Wurbs, S. Ruf, B. Bock, 2007Contained metabolic engineering in tomatoes by expression of carotenoid biosynthesis genes from the plastid genome. The Plant Journal, 49276288
120 - A. Yasmeen, B. Mirza, S. Inayatullah, N. Safdar, M. Jamil, S. Ali, M. F. Choudhry, 2009In planta transformation of tomato. Plant Molecular Biology Reporter, 272028
121 - J. W. Youm, J. H. Jeon, H. Kim, Y. H. Kim, K. Ko, H. Joung, H. Kim, 2008Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer`s disease. Biotechnology Letters, 3018391845
122 - M. I. Zanor, S. Osorio, A. Nunes-Nesi, F. Carrari, M. Lohse, B. Usadel, C. Kuhn, W. Bleiss, P. Giavalisco, L. Willmitzer, R. Sulpice, Y. H. Zhou, A. R. Fernie, 2009RNA interference of LIN5 in tomato confirms its role in controlling Brix content, uncovers the influence of sugars on the levels of fruit hormones, and demonstrates the importance of sucrose cleavage for normal fruit development and fertility. Plant Physiology, 15012041218
123 - C. Zhang, J. Liu, Y. Zhang, X. Cai, P. Gong, J. Zhang, T. Wang, H. Li, Z. Ye, 2011Overexpression of SlGMEs leads to ascorbate accumulation with enhanced oxidative stress, cold, and salt tolerance in tomato. Plant Cell Reports, 30389398
124 - X. Zhang, N. A. Buehner, A. M. Hutson, M. L. Estes, H. S. Mason, 2006Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnology Journal, 4419432
125 - X. Zhang, H. Li, J. Zhang, C. Zhang, P. Gong, K. Ziaf, F. Xiao, Z. Ye, 2010Expression of artificial microRNAs in tomato confers efficient and stable virus resistance in a cell-autonomous manner. Transgenic Research, doi:10.1007/s11248-010-9440-3
126 - F. Zhou, J. A. Badillo-Corona, D. Karcher, N. Gonzalez-Rabade, K. Piepenburg, A. M. Borchers, A. P. Maloney, T. A. Kavanagh, J. C. Gray, R. Bock, 2008High-level expression of human immunodeficiency virus antigens from the tobacco and tomato plastid genomes. Plant Biotechnology Journal, 6897913